Neptune Technologies & Bioressources Inc. v. Mercola.com Health Resources LLC
1:12-cv-01253
Overview
Parties
Defendant
Mercola.com Health Resources LLC Operating Company
Represented By
1 Attorneys ListedADDRESS EXPIRED / UNKNOWN
ADDRESS EXPIRED / UNKNOWN, (302) 888-6800
Enzymotec USA Inc. Operating Company
Represented By
2 Attorneys ListedADDRESS EXPIRED / UNKNOWN
ADDRESS EXPIRED / UNKNOWN, (302) 888-6800
ADDRESS EXPIRED / UNKNOWN
ADDRESS EXPIRED / UNKNOWN, (302) 888-6800
Enzymotec Limited NPE (University / Research)
Represented By
2 Attorneys ListedADDRESS EXPIRED / UNKNOWN
ADDRESS EXPIRED / UNKNOWN, (302) 888-6800
ADDRESS EXPIRED / UNKNOWN
ADDRESS EXPIRED / UNKNOWN, (302) 888-6800
Plaintiff
Neptune Technologies & Bioressources Inc. Operating Company
Represented By
3 Attorneys ListedDelaware Department of Justice
Delaware Department of Justice, 820 North French Street
Ashby & Geddes
Ashby & Geddes, 500 Delaware Avenue, 8th Floor
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 11 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | US 8,278,351 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 8,680,080 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2012021477 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 8,383,675 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2013020268 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2015003846 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2015016492 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 10,028,968 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 30,784,201 P | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 8,030,348 B2 | US Continuation / Sibling | View Official Patent → |
| π PCT International (WIPO) | WO 2003011873 A2 | PCT World Application | View Official Patent → |
Enzymotec Ltd. et al. v. Neptune Technologies and Bioressources Inc.
Enzymotec Ltd. et al. v. Neptune Technologies & Bioressources Inc.
Enzymotec Ltd. et al. v. Neptune Technologies & Bioressources Inc.
Enzymotec Ltd. et al. v. NEPTUNE TECHNOLOGIES & BIORESSOURCES, INC.
Aker BioMarine AS v. NEPTUNE TECHNOLOGIES & BIORESSOURCES, INC.
Aker Biomarine AS v. Neptune Technologies and Bioressources Inc.
Patents Involved
There is a single patent involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US8278351
Natural marine source phospholipids comprising polyunsaturated fatty acids and their applications
|
Filed: 2011-07-25
Issued: 2012-10-02
|
Active (4.7 yrs remaining)
Expires: 2031-07-25
|
Patent Enforceability & Injunction Risk Assessment
Active Threat β Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.
Standard Statutory Term β No obviousness-type double patenting truncation noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).
Procedural Motions & Interlocutory Orders
Total Motions
13
Dispositive
7
Granted
2
Denied
0
Pending / Review
9
Motions by Category
Key Dispositive Motions & Rulings